|
|
 |
|
Viewing report
|
|
|
|
Top 10 Companies in the UK Life Sciences Industry: IT Spending Predictor 2010
Datamonitor, Sep 2010, Pages: 114
This databook provides estimates of IT spending for the top 10 companies in the UK Life sciences industry. The databook is a comprehensive source of IT spending by company, including assessment by technology and channel. The databook also provides information on the IT contracts of these companies where available.
- The view of the top 10 companies in the UK Life sciences sector in terms of IT spending
- A breakdown of the estimated IT budget by technology for each of the top 10 companies
- A breakdown of the estimated IT budget by channel for each of the top 10 companies
- Details of IT services contracts by company where available
The top 10 companies in the UK life sciences industry in terms of estimated IT spending spent the largest portion of their IT budgets on services, a segment that accounted for about 28% of the IT budgets among these firms. This was followed by spending on hardware and software.
Among the top 10 companies, a major portion of IT spending is allocated to internal IT. Internal IT alone accounted for approximately 30% of the total estimated IT spending by these companies. GlaxoSmithKline Plc remained the leading company in terms of IT spending, followed by AstraZeneca Plc and GE Healthcare.
- Gain insight into IT budget breakdown of top10 companies in UK life sciences industry and identify notable areas of allocation
- Identify organizations with top IT expenditures in your target markets
- Leverage IT spending pattern information to tailor account targeting based on company demographics
Customers who bought this item also bought
Bio/Pharma R&D Statistical Sourcebook 2010/2011
Industry Snapshot: How Companies Are Using M&As to Strategic Advantage
Global and China Biopharmaceutical Industry Report, 2010
Global and China Biopharmaceutical Industry Report, 2010
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Option and Evaluation Agreements in Pharma and Biotech, 2nd Edition
Stem Cells in Regenerative Medicine: Benchmarking Analysis of Big Companies Entering the Market
Strategies for Building Biologics Capabilities and Franchises
Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th Edition
|
|
|
|
